Clinical Trials Browser

Phase 4 × rozanolixizumab × 90 days × Clear all

NCT07246564 2026-05-22

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Phase 4 Recruiting

Myasthenia Gravis